Patent · US Active

Pharmaceutical combination and use thereof

US12233047B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignees

ASCENTAGE PHARMA (SUZHOU) CO., LTD. · CN
ASCENTAGE PHARMA GROUP CORP LIMITED · CN

Inventors

Yifan Zhai · Suzhou, CN
Dajun Yang · Suzhou, CN
Douglas Dong FANG · Suzhou, CN
Qiuqiong Tang · Suzhou, CN

Key dates

Filing date	Jul 16, 2020
Grant date	Feb 25, 2025
Priority date	—
Expiry date	Jul 29, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention discloses a novel pharmaceutical combination and a use thereof. The pharmaceutical combination comprises a compound of formula (I), a pharmaceutically acceptable salt thereof or a solvate thereof; and a compound of formula (II), a pharmaceutically acceptable salt thereof or a solvate thereof. The pharmaceutical combination can be used to treat cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.